A detailed history of Aqr Capital Management LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 14,000 shares of HAE stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,000
Previous 83,988 83.33%
Holding current value
$1.19 Million
Previous $6.95 Million 83.81%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.45 - $91.58 $5.07 Million - $6.41 Million
-69,988 Reduced 83.33%
14,000 $1.13 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $3.64 Million - $4.36 Million
-44,787 Reduced 34.78%
83,988 $6.95 Million
Q1 2024

May 15, 2024

SELL
$71.24 - $85.35 $722,587 - $865,705
-10,143 Reduced 7.3%
128,775 $11 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $4.64 Million - $5.33 Million
-57,579 Reduced 29.3%
138,918 $11.9 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $873,815 - $989,498
-10,584 Reduced 5.11%
196,497 $17.6 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $4.67 Million - $5.17 Million
57,790 Added 38.71%
207,081 $17.6 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $6.55 Million - $8.16 Million
90,092 Added 152.19%
149,291 $12.4 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $1.25 Million - $1.46 Million
16,916 Added 40.01%
59,199 $4.66 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $2.21 Million - $2.74 Million
34,849 Added 468.78%
42,283 $3.13 Million
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $900,606 - $1.21 Million
-18,279 Reduced 71.09%
7,434 $481,000
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $818,674 - $1.18 Million
18,704 Added 266.86%
25,713 $1.61 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $3.08 Million - $4.64 Million
-62,216 Reduced 89.88%
7,009 $372,000
Q3 2021

Nov 15, 2021

SELL
$57.6 - $70.59 $1.26 Million - $1.54 Million
-21,870 Reduced 24.01%
69,225 $4.89 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $2.92 Million - $6.67 Million
56,287 Added 161.71%
91,095 $6.02 Million
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $2.52 Million - $3.17 Million
-22,706 Reduced 39.48%
34,808 $3.86 Million
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $2.09 Million - $2.82 Million
-23,527 Reduced 29.03%
57,514 $6.82 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $1.71 Million - $2.12 Million
22,640 Added 38.77%
81,041 $6.98 Million
Q2 2020

Aug 17, 2020

BUY
$84.96 - $118.91 $1.27 Million - $1.78 Million
14,964 Added 34.45%
58,401 $5.12 Million
Q1 2020

May 15, 2020

SELL
$74.34 - $121.82 $8.05 Million - $13.2 Million
-108,264 Reduced 71.37%
43,437 $4.33 Million
Q4 2019

Feb 14, 2020

SELL
$114.37 - $129.46 $16.9 Million - $19.1 Million
-147,400 Reduced 49.28%
151,701 $17.4 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $43.6 Million - $51.6 Million
-372,530 Reduced 55.47%
299,101 $37.7 Million
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $33.7 Million - $49.6 Million
-411,879 Reduced 38.01%
671,631 $80.2 Million
Q1 2019

May 14, 2019

BUY
$83.25 - $102.12 $17.9 Million - $22 Million
215,054 Added 24.76%
1,083,510 $94.8 Million
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $38.1 Million - $49.1 Million
420,673 Added 93.95%
868,456 $86.9 Million
Q3 2018

Nov 15, 2018

BUY
$89.96 - $114.58 $24.3 Million - $31 Million
270,157 Added 152.09%
447,783 $51.3 Million
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $5.88 Million - $7.87 Million
82,213 Added 86.17%
177,626 $15.9 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $5.1 Million - $6.25 Million
84,057 Added 740.2%
95,413 $6.98 Million
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $296,376 - $388,862
6,592 Added 138.37%
11,356 $660,000
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $192,370 - $213,760
4,764
4,764 $214,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.